However, RelB expression was associated with clinical features of patients only during exacerbation, suggesting that RelB may represent a novel marker of health outcomes, in particular cardiovascular, during exacerbation in COPD. This evidence concerns the gene RELB and chronic obstructive pulmonary disease.